Intra-Cellular Therapies to Present at the 2020 RBC Capital Markets Global Healthcare Conference
May 14 2020 - 8:00AM
Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical
company focused on the development and commercialization of
therapeutics for central nervous system (CNS) disorders, today
announced that Sharon Mates, Ph.D., Chief Executive Officer and
Chairman, is scheduled to present at the 2020 RBC Capital Markets
Global Healthcare Conference. The presentation is scheduled for
Tuesday, May 19, 2020 at 9:10 am ET.The live and archived webcast
can be accessed under "Press Releases & Events" in the Investor
Relations section of the Company's website at
www.intracellulartherapies.com. Please log in approximately 5-10
minutes prior to the event to register and to download and install
any necessary software.
About Intra-Cellular Therapies
Intra-Cellular Therapies is a biopharmaceutical
company founded on Nobel prize-winning research that allows us to
understand how therapies affect the inner-workings of cells in the
body. The company leverages this intracellular approach to develop
innovative treatments for people living with complex psychiatric
and neurologic diseases. For more information, please visit
www.intracellulartherapies.com.
Contact
Intra-Cellular Therapies, Inc.Juan Sanchez, M.D.Vice President,
Corporate Communications and Investor Relations646-440-9333
Burns McClellan, Inc.Lisa
Burnsjgrimaldi@burnsmc.com212-213-0006
MEDIA INQUIRIES:
Ana FullmerCorporate Media Relations
W2Owcgafullmer@wcgworld.com202-507-0130
Source: Intra-Cellular Therapies Inc.
Intra Cellular Therapies (NASDAQ:ITCI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Intra Cellular Therapies (NASDAQ:ITCI)
Historical Stock Chart
From Apr 2023 to Apr 2024